Cardiovascular Events, Malignancies, and Efficacy Outcomes in Latin American Patients with Rheumatoid Arthritis Receiving Tofacitinib or Tumor Necrosis Factor Inhibitors
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY(2024)
关键词
Janus kinase inhibitor,Latin America,rheumatoid arthritis,TNFi,tofacitinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要